 Furthermore, DDI risk increases dramatically with age, with patients age 70-79 having a 50-fold risk increase in comparison to patients aged 0-19 . Interestingly, several null models demonstrate that this risk increase is not due to increased polypharmacy with age.
<clarity>  Furthermore, DDI risk increases dramatically with age, with patients age 70-79 having a 50-fold risk increase in comparison to patients aged 0-19 . Interestingly, several null models demonstrate that this risk increase is not due to increased polypharmacy with age.
 Furthermore, DDI risk increases substantially with age. Patients aged 70-79 having a 50-fold risk increase in comparison to patients aged 0-19 . Interestingly, several null models demonstrate that this risk increase is not due to increased polypharmacy with age.